1. Home
  2. AIT vs CYTK Comparison

AIT vs CYTK Comparison

Compare AIT & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Industrial Technologies Inc.

AIT

Applied Industrial Technologies Inc.

HOLD

Current Price

$338.26

Market Cap

12.5B

Sector

Industrials

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$78.55

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIT
CYTK
Founded
1923
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
10.7B
IPO Year
1994
2004

Fundamental Metrics

Financial Performance
Metric
AIT
CYTK
Price
$338.26
$78.55
Analyst Decision
Buy
Strong Buy
Analyst Count
5
19
Target Price
$317.50
$89.26
AVG Volume (30 Days)
238.0K
1.8M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
0.69%
N/A
EPS Growth
8.20
N/A
EPS
10.95
N/A
Revenue
$21,485,000.00
$13,368,000.00
Revenue This Year
$7.79
$7.37
Revenue Next Year
$5.45
$310.19
P/E Ratio
$31.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$238.34
$35.22
52 Week High
$374.80
$88.31

Technical Indicators

Market Signals
Indicator
AIT
CYTK
Relative Strength Index (RSI) 45.27 51.89
Support Level $331.42 $78.27
Resistance Level $345.48 $79.66
Average True Range (ATR) 7.85 2.07
MACD -2.67 0.36
Stochastic Oscillator 12.14 82.91

Price Performance

Historical Comparison
AIT
CYTK

About AIT Applied Industrial Technologies Inc.

Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: